Backing innovation for over 50 years

Backing innovation for over 50 years

Solving the puzzle of cancer

We support novel research by our grantees, giving them the time and resources needed to take an intuitive idea into innovative breakthroughs. And those discoveries can take significant amounts of time. Whether it is translating new scientific information into advanced cancer management approaches or improving treatment delivery for better outcomes and quality of life, The Foundation’s grantees are doing work that can change patients’ lives.

Solving the puzzle of cancer

We support novel research by our grantees, giving them the time and resources needed to take an intuitive idea into innovative breakthroughs. And those discoveries can take significant amounts of time. Whether it is translating new scientific information into advanced cancer management approaches or improving treatment delivery for better outcomes and quality of life, The Foundation’s grantees are doing work that can change patients’ lives.

Meet our grantees

Antonio Iavarone, MD

Brain Cancer

+
Sandra Demaria, MD

Breast Cancer

+
Doris Germain, MD

Breast Cancer

+
Sylvia Adams, MD

Breast Cancer

+
Steven Itzkowitz, MD

GI Cancers

+
Samir Parekh, MD

Hematological Cancer

+
Ari Melnick, MD

Hodgkin's and Non-Hodgkin's Lymphomas

+
Iannis Alfantis, PhD

Leukemia

+
Iman Osman, MD

Malignant Melanomas

+

Meet our grantees

Antonio Iavarone, MD

Brain Cancer

+
Sandra Demaria, MD

Breast Cancer

+
Doris Germain, MD

Breast Cancer

+
Sylvia Adams, MD

Breast Cancer

+
Steven Itzkowitz, MD

GI Cancers

+
Samir Parekh, MD

Hematological Cancer

+
Ari Melnick, MD

Hodgkin's and Non-Hodgkin's Lymphomas

+
Iannis Alfantis, PhD

Leukemia

+
Iman Osman, MD

Malignant Melanomas

+

The Chemotherapy+ Foundation understands that it takes decades for research to translate into treatment. Most of our researchers are funded for at least 5 to 10 years except for special one-time grants.

A history of funding breakthroughs

2008
Adolfo Ferrando, MD, PhD
Columbia University Medical
Center, Institute of
Cancer Genetics
Studies strategies to increase remission rates for Leukemia.


2006
Robert Fine, MD
Columbia University Medical
Center, Division of
Medical Oncology Clinical Research
Developed treatment regimens for pancreatic cancer and was the first to exploit BRCA mutation.
2005
Peter Brooks, MD
NYU School of Medicine,
Department of Radiation
Oncology and Cell Biology
Basic research and innovation strategies for the early detection and treatment of malignant tumors.

2004
Anna Ferrari, MD
NYU School of Medicine
Clinical Care Center
Genomic analysis of prostate cancer led to several trials of androgen receptor modulation.



2004
Leonard Liebes, MD
NYU School of Medicine
Division of Medical Oncology
Developed a new method of delivering chemotherapy in treating ovarian cancer.



2004
Joseph Locker, MD, PhD
Albert Einstein College
of Medicine, Department of
Pathology
Studied tumor suppressor genes in adenocarcinoma and squamous cell cancers of the lung.

Identifying future developments for over 50 years